ACTIVE

DECORTE APOTHEEK

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

89,8 k €

+44.2% YoY

Gross margin

362,1 k €

+26.6% YoY

Equity

324,4 k €

+0.6% YoY

Workforce

2,1 ETP

+5.0% YoY

What does DECORTE APOTHEEK do?

DECORTE APOTHEEK is a Public limited company incorporated in 1997. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Torhout. It employs on average 2,1 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0462.205.097

Incorporation

23/12/1997

Legal form

Public limited company

Registered office

Hofstraat 26
8820 Torhout · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

2,1 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 68201Rental and operating of own or leased real estate 68203Rental and operating of own or leased real estate

Joint committees (1)

Contacts

4 public details availableLog in to view

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2009		2008		2007		2006
Income statement
Gross margin	362,1 k €	+26.6%	286,1 k €	-10.4%	319,2 k €	+3.4%	308,9 k €	+2.9%	300,2 k €	+32.2%	227,1 k €	+49.0%	152,4 k €	-17.5%	184,7 k €	-4.2%	192,8 k €	-13.1%	221,8 k €	-3.9%	230,8 k €	+7.4%	214,9 k €	+4.0%	206,8 k €	-12.0%	234,9 k €	+13.5%	206,9 k €	+9.6%	188,7 k €	+10.3%	171,1 k €
EBITDA	177,3 k €	+38.2%	128,3 k €	+2.3%	125,5 k €	+2.6%	122,3 k €	-23.0%	159 k €	+35.4%	117,4 k €	+181%	41,8 k €	-39.6%	69,3 k €	-16.6%	83,1 k €	-23.2%	108,1 k €	-10.2%	120,4 k €	+17.8%	102,2 k €	-1.4%	103,6 k €	-9.6%	114,6 k €	+12.2%	102,2 k €	+2.8%	99,4 k €	+23.2%	80,7 k €
Operating result	115,8 k €	+38.5%	83,6 k €	-15.1%	98,5 k €	+2.2%	96,4 k €	-27.7%	133,2 k €	+49.5%	89,1 k €	+654%	11,8 k €	-56.1%	26,9 k €	-30.0%	38,4 k €	-37.0%	61 k €	-15.7%	72,4 k €	+76.3%	41 k €	+29.9%	31,6 k €	-23.3%	41,2 k €	+62.1%	25,4 k €	+88.1%	13,5 k €	-52.6%	28,5 k €
Net result	89,8 k €	+44.2%	62,3 k €	-22.4%	80,3 k €	-5.6%	85,1 k €	-30.0%	121,5 k €	+77.2%	68,5 k €	+3183%	-2,2 k €	-133%	6,7 k €	-59.6%	16,6 k €	-43.3%	29,3 k €	-25.5%	39,4 k €	+210%	12,7 k €	+840%	1,4 k €	-75.2%	5,5 k €	+155%	-10 k €	-534%	-1,6 k €	-112%	13,5 k €
Balance sheet
Equity	324,4 k €	+0.6%	322,6 k €	+8.5%	297,3 k €	+0.1%	297 k €	+0.2%	296,4 k €	+2.4%	289,6 k €	+0.2%	289,1 k €	-0.8%	291,3 k €	+2.4%	284,6 k €	+4.3%	272,9 k €	+9.3%	249,6 k €	+10.8%	225,2 k €	+6.0%	212,5 k €	-1.0%	214,6 k €	+2.6%	209,2 k €	-4.6%	219,2 k €	-0.7%	220,7 k €
Total assets	1,1 M €	+1.4%	1,1 M €	+46.2%	727,1 k €	-1.8%	740,8 k €	-8.3%	807,6 k €	+3.8%	778,2 k €	+4.4%	745,3 k €	-6.2%	794,4 k €	-13.0%	913,2 k €	+7.0%	853,5 k €	-6.4%	912,3 k €	-1.4%	924,8 k €	-6.8%	991,7 k €	-10.6%	1,1 M €	-8.1%	1,2 M €	+52.5%	792,1 k €	+141%	329,3 k €
Cash	126,5 k €	+8.6%	116,4 k €	+51.2%	77 k €	+17.3%	65,7 k €	-47.1%	124 k €	+130%	53,9 k €	+32.3%	40,7 k €	-15.8%	48,4 k €	-42.9%	84,7 k €	+124%	37,8 k €	-32.3%	55,9 k €	+51.9%	36,8 k €	+21.2%	30,4 k €	+57.5%	19,3 k €	-86.5%	143,2 k €	+53.4%	93,3 k €	+63.9%	56,9 k €
Debts	749,3 k €	+1.9%	735,5 k €	+72.8%	425,7 k €	-3.3%	440,2 k €	-13.3%	507,9 k €	+4.0%	488,6 k €	+7.2%	455,7 k €	-9.1%	501,4 k €	-20.1%	627,6 k €	+8.3%	579,5 k €	-11.7%	656,6 k €	-5.4%	694,4 k €	-10.9%	779,2 k €	-12.9%	895,1 k €	-10.4%	998,9 k €	+74.4%	572,9 k €	+433%	107,5 k €
Other
Workforce	2,1 ETP	+5.0%	2,0 ETP	-28.6%	2,8 ETP	0.0%	2,8 ETP	-15.2%	3,3 ETP	+94.1%	1,7 ETP	-37.0%	2,7 ETP	+42.1%	1,9 ETP	+11.8%	1,7 ETP	0.0%	1,7 ETP	-5.6%	1,8 ETP	-5.3%	1,9 ETP	+11.8%	1,7 ETP	-22.7%	2,2 ETP	-18.5%	2,7 ETP	+17.4%	2,3 ETP	0.0%	2,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 17 ended

Active mandates

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte Elke

Active

Ended mandates

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte ELKE

Ended

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte ELKE

Ended

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte Elke

Ended

DECURA PHAR

Managing director · since 30 juin 2018 · until 30 juin 2024 · 0833.331.354

Represented by Decorte Elke

Ended

At this address

Other companies at this address

Company	CBE no.
DECURA PHAR● Active	0833.331.354

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	08/07/2026	14/07/2025	02/07/2024	28/06/2023	29/09/2022	05/07/2021
General meeting	11/06/2026	12/06/2025	13/06/2024	08/06/2023	30/06/2022	10/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	11/06/2026	08/07/2026	Dutch	PDF
Abridged model	31/12/2024	12/06/2025	14/07/2025	Dutch	PDF
Abridged model	31/12/2023	13/06/2024	02/07/2024	Dutch	PDF
Abridged model	31/12/2022	08/06/2023	28/06/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	29/09/2022	Dutch	PDF
Abridged model	31/12/2020	10/06/2021	05/07/2021	Dutch	PDF
Abridged model	31/12/2019	11/06/2020	29/06/2020	Dutch	PDF
Abridged model	31/12/2018	13/06/2019	09/07/2019	Dutch	PDF
Abridged model	31/12/2017	30/06/2018	29/08/2018	Dutch	PDF
Abridged model	31/12/2016	29/06/2017	14/07/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	15/07/2016	Dutch	PDF
Abridged model	31/12/2014	11/06/2015	26/08/2015	Dutch	PDF
Abridged model	31/12/2013	12/06/2014	30/09/2014	Dutch	PDF
Abridged model	31/12/2012	13/06/2013	17/03/2014	Dutch	PDF
Abridged model	31/12/2011	14/06/2012	31/08/2012	Dutch	PDF
Abridged model	31/12/2009	10/06/2010	21/09/2010	Dutch	PDF
Abridged model	31/12/2008	11/06/2009	27/08/2009	Dutch	PDF
Abridged model	31/12/2007	10/06/2008	29/08/2008	Dutch	PDF
Abridged model	31/12/2006	28/06/2007	28/08/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 17 ended

Active mandates

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte Elke

Active

Ended mandates

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte ELKE

Ended

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte ELKE

Ended

DECURA PHAR

Director · since 26 juin 2019 · 0833.331.354

Represented by Decorte Elke

Ended

DECURA PHAR

Managing director · since 30 juin 2018 · until 30 juin 2024 · 0833.331.354

Represented by Decorte Elke

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates03/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Other20/08/2021
DIVERSEN
PDF
Mandates29/07/2019
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates29/01/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates31/10/2017
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/03/2011
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/02/2004
ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202589,8 k €↑
2024
Annual accounts 202462,3 k €↓
2023
Annual accounts 202380,3 k €↓
2022
Annual accounts 202285,1 k €↓
2021
Annual accounts 2021121,5 k €↑
2018
Annual accounts 201868,5 k €↑
2017
Annual accounts 2017-2,2 k €↓
2016
Annual accounts 20166,7 k €↓
2015
Annual accounts 201516,6 k €↓
2014
Annual accounts 201429,3 k €↓
2013
Annual accounts 201339,4 k €↑
2012
Annual accounts 201212,7 k €↑
2011
Annual accounts 20111,4 k €↓
2009
Annual accounts 20095,5 k €↑
2008
Annual accounts 2008-10 k €↓
2007
Annual accounts 2007-1,6 k €↓
2006
Annual accounts 200613,5 k €
23/12/1997
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DECORTE APOTHEEK

Overview

What does DECORTE APOTHEEK do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline